It seems to me that who supplies our vaccine either before or after approval doesn't matter as long as what they provide meet the standards set by the company, and accepted by the regulators. The key is, we profit from any product that's sold, as well as our cost being acceptable when using what's provided in trials.
Should we gain a partnership, or buyout, it would be up to the partner or buyer to reach an agreement on how product will be manufactured. Will they want to do it in house, or maintain current suppliers, that would be up to them.
Our consideration should be, what is NWBO doing, as long as they don't own the manufacturing sites, it shouldn't be of that great a concern to us as long as they're sufficient to meet the demand once we have an approval.
With all my medical treatment I take a lot of drugs. Frankly I don't worry about who they come from, some are generic, others still under patent, but regardless, a drug with a BP label may still be produced by someone contracted by the BP. Perhaps this may concern some, but to me, as long as the drugs are working as the Dr. intends them to, I'm fine with whoever is the source.
I do believe that it's sad that Doctors must fight to put patients on drugs still under patent, as the price is generally much higher. I recently had a change in blood pressure meds and the Dr. anticipated a fight, but it didn't occur because a generic form of the drug is now available. The problem is this philosophy is preventing the sale of a lot of newly approved medications, and they're often being withheld from the patients until all available generic alternatives have been tried. I'm not saying this would be the case with deadly diseases like cancer, but SOC treatment will be tried first until the newly approved drug becomes part of the SOC.
I have great drug coverage, but I know people who don't, they routinely drive down to Tijuana and purchase drugs at price that are lower than what I pay, but not enough to make it worth the trip. In almost every case, their drugs carry the names of BP's, but those BP's produce their drugs in Mexico. I don't believe they've had a problem from the drugs, but I think that it's interesting that down there the retail price is lower than the price I pay which is supposed to be a small fraction of the total cost, with the insurance paying the difference. I should note that in Mexico, most of those drugs do not require a prescription.
Gary
